Trial intelligence / Profile preview

Thiamine vs Promethazine for Nausea and Vomiting in Pregnancy

NCT00861523Phase 3Terminated

Sponsor
Emek Medical Center
Start
Feb 2009
Primary completion
Jan 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial of thiamine in hyperemesis gravidarum (HG) (2 arms), sponsored by Emek Medical Center. Primary endpoint: Improvement in nausea and/or vomiting at 2 months. Started Feb 2009; status: terminated.

02

Drugs

thiamine
03

Conditions

hyperemesis gravidarum (HG)

Beyond the preview

Go deeper on NCT00861523.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00861523.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call